Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
Authors:
- Andrei Emilian PopaAPAndrei Emilian Popa
- Elena PopaEPElena Popa
- Tatiana DrambaTDTatiana Dramba
- Elena Adorata ComanECElena Adorata Coman
- Mihaela PorochMPMihaela Poroch
- Monica UngureanuMUMonica Ungureanu
- Agnes BacuscaABAgnes Bacusca
- Ana Maria SlaninaASAna Maria Slanina
- Gema BacoanuGBGema Bacoanu
- Vladimir PorochVPVladimir Poroch
Open Access
- 25 November 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11383
Abstract
Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.Keywords
This publication has 153 references indexed in Scilit:
- Synergistic Modulating of Mitochondrial Transfer and Immune Microenvironment to Attenuate Discogenic PainAdvanced Science, 2025
- Microglia regulate myelin clearance and cholesterol metabolism after demyelination via interferon regulatory factor 5Cellular and Molecular Life Sciences, 2025
- Vaccine Based Approaches for the Prevention and Treatment of Neurological DiseaseCurrent Treatment Options in Neurology, 2025
- Moving towards the use of artificial intelligence in pain managementEuropean journal of pain, 2024
- Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approachesGeroScience, 2024
- A protectin DX (PDX) analog with in vitro activity against influenza A(H1N1) virusesJournal of Medical Virology, 2024
- Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic SclerosisArthritis & Rheumatology, 2023
- COVID‐19 metabolism: Mechanisms and therapeutic targetsMedcomm, 2022
- Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk ReductionRevista Brasileira de Farmacognosia, 2021
- Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?Archives of Medical Research, 2020